Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1990;67:272-283

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holmberg, S. R.
Right arrow Articles by Williams, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holmberg, S. R.
Right arrow Articles by Williams, A. J.

Circulation Research, Vol 67, 272-283, Copyright © 1990 by American Heart Association


ARTICLES

Patterns of interaction between anthraquinone drugs and the calcium- release channel from cardiac sarcoplasmic reticulum

SR Holmberg and AJ Williams
Department of Cardiac Medicine, National Heart & Lung Institute, London, UK.

We have studied the effects of clinically useful anthraquinones on the cardiac sarcoplasmic reticulum calcium-release channel. Micromolar concentrations of doxorubicin and other anthracyclines at the cytosolic face of the channel significantly and reversibly increase the open probability of single channels in artificial phospholipid bilayers. Lifetime analysis shows that anthracyclines and calcium are synergistic activators of the calcium-release channel. Radiolabeled ryanodine binding suggests that all the anthracyclines studied are equally potent as channel activators in vitro. Mitoxantrone, an anthracenedione derivative, variably increases channel open probability at low (1-10 microM) concentrations. Higher concentrations are associated with the appearance of channel currents with lower amplitudes than the fully open state, and normal openings are reduced in frequency. At these concentrations, the interaction of mitoxantrone with the channel reduces the level of ryanodine binding. Abnormal function of the cardiac calcium-release channel will alter calcium handling within the myocyte and may be the basis for anthraquinone-related cardiotoxicity.


This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
J Butany, E Ahn, and A Luk
Drug-related cardiac pathology
J. Clin. Pathol., December 1, 2009; 62(12): 1074 - 1084.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Weiss and W. Kang
P-Glycoprotein Inhibitors Enhance Saturable Uptake of Idarubicin in Rat Heart: Pharmacokinetic/Pharmacodynamic Modeling
J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 688 - 694.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G.-X. Wang, X.-B. Zhou, and M. Korth
Effects of Mitoxantrone on Excitation-Contraction Coupling in Guinea Pig Ventricular Myocytes
J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 501 - 508.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
W. Feng, G. Liu, R. Xia, J. J. Abramson, and I. N. Pessah
Site-Selective Modification of Hyperreactive Cysteines of Ryanodine Receptor Complex by Quinones
Mol. Pharmacol., May 1, 1999; 55(5): 821 - 831.
[Abstract] [Full Text]


Home page
JGPHome page
B. Tanna, W. Welch, L. Ruest, J. L. Sutko, and A. J. Williams
Interactions of a Reversible Ryanoid (21-Amino-9{alpha}-Hydroxy-Ryanodine) with Single Sheep Cardiac Ryanodine Receptor Channels
J. Gen. Physiol., July 1, 1998; 112(1): 55 - 69.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
R. Zucchi and S. Ronca-Testoni
The Sarcoplasmic Reticulum Ca2+ Channel/Ryanodine Receptor: Modulation by Endogenous Effectors, Drugs and Disease States
Pharmacol. Rev., March 1, 1997; 49(1): 1 - 52.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y.-X. Wang and M. Korth
Effects of Doxorubicin on Excitation-Contraction Coupling in Guinea Pig Ventricular Myocardium
Circ. Res., April 1, 1995; 76(4): 645 - 653.
[Abstract] [Full Text]